16 Jan HPTN084

  A Phase 3 Double Blind Safety and Efficacy Study of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women. HPTN084 is a study being done to to evaluate the safety and efficacy of the injectable...